AI | pharmaphorum

AI

Patients

The rise of prescription drug abuse and drug diversion

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased.

Digital

AI and the Big Data paradigm – big ambitions in novel drug d...

Over the past few decades, data generation has veritably exploded.

Digital

It’s time for more tech and biotech innovation in 2023

The drive to make the UK a ‘scientific powerhouse’ was central to the government’s

Digital

A few of 2022’s biggest pharma trends – the pharmaphorum pod...

As we close out the year, pharmaphorum's editorial team sat down together for a roundtable discussion of some of the biggest trends they tracked this year in the world of

Digital

Curavit’s crystal ball – how will 2023 drive meaningful chan...

The life sciences industry is flexing towards innovation in new areas, faster than ever before, and increasing patient care in astonishing ways.

News

AI innovator Quris seed funding grows to $37 million

Quris, an artificial intelligence (AI) innovator in the pharmaceutical arena, has secured an additional $9 million in seed funding, expanding its

The rise of prescription drug abuse and drug diversion

AI and the Big Data paradigm – big ambitions in novel drug d...

It’s time for more tech and biotech innovation in 2023

A few of 2022’s biggest pharma trends – the pharmaphorum pod...

Curavit’s crystal ball – how will 2023 drive meaningful chan...

AI innovator Quris seed funding grows to $37 million

Infex chases after Insmed with bronchiectasis trial win

Discover a new era of healthcare panel engagement: Grounded ...

AI

Editor's Picks